Pfizer (PFE) Liabilities from Discontinued Operations (2010 - 2019)
Pfizer's (PFE) quarterly Liabilities from Discontinued Operations came in at $2.4 billion in Q4 2019, up 27.67% year-over-year from $1.9 billion in Q4 2018, and up 20.11% quarter-over-quarter from $2.0 billion in Q2 2019.
Powered by 
Analysis
Pfizer (PFE) Liabilities from Discontinued Operations (2010 - 2019) Analysis & Trends
Pfizer (PFE) has reported Liabilities from Discontinued Operations for 6 consecutive years, with $2.4 billion the latest figure, recorded in Q4 2019.
- On a quarterly basis, Liabilities from Discontinued Operations rose 27.67% year-over-year to $2.4 billion in Q4 2019; TTM through Dec 2019 was $2.4 billion, a 27.67% increase from a year earlier, with the FY2019 full-year figure at $2.4 billion, up 27.67% from the prior year.
- Liabilities from Discontinued Operations was $2.4 billion for Q4 2019 at Pfizer, up from $2.0 billion in the prior quarter.
- Over five years, Liabilities from Discontinued Operations peaked at $2.4 billion in Q4 2019 and troughed at $1.9 billion in Q4 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 2.41 Bn |
| Jun 30, 2019 | 2.01 Bn |
| Mar 31, 2019 | 1.94 Bn |
| Dec 31, 2018 | 1.89 Bn |
| Dec 31, 2013 | 21.00 Mn |
| Sep 29, 2013 | 21.00 Mn |
| Jun 30, 2013 | 21.00 Mn |
| Dec 31, 2012 | 1.44 Bn |
| Sep 30, 2012 | 1.41 Bn |
| Jul 1, 2012 | 1.30 Bn |
| Dec 31, 2011 | 1.22 Bn |
| Jul 3, 2011 | 181.00 Mn |
| Apr 3, 2011 | 182.00 Mn |
| Dec 31, 2010 | 151.00 Mn |